Baylor College Of Medicine
Clinical trials sponsored by Baylor College Of Medicine, explained in plain language.
-
New hope for kids with blood cancer in malawi: tailored treatment study launches
Disease control Recruiting nowThis study is testing a treatment guideline designed for children with acute myeloid leukemia (AML) in Malawi, where resources are limited. It will enroll 30 children under 18 to see if the adapted plan is both feasible and effective at achieving remission. The goal is to improve…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 09:08 UTC
-
Immune cells trained to hunt virus could fight lymphoma
Disease control Recruiting nowThis study tests a new way to make immune cells (T cells) that can attack cancer cells infected with the Epstein-Barr virus (EBV). The cells are grown faster in the lab and given to patients with Hodgkin or non-Hodgkin lymphoma, or related diseases that have come back or not gone…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 09:08 UTC
-
Supercharged immune cells take aim at childhood cancer
Disease control Recruiting nowThis study tests a new treatment for children with neuroblastoma that has come back or not responded to standard therapy. Researchers take the child's own immune cells (called NKT cells), add a special receptor to help them recognize and attack the cancer, and also add a molecule…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 09:07 UTC
-
Supercharged donor cells take on stubborn lymphomas
Disease control Recruiting nowThis early-stage study tests a new approach for people with certain lymphomas (like Hodgkin lymphoma) that have come back or not responded to standard treatments. Researchers take immune cells from healthy donors, add a special receptor (C7R) to help them survive longer, and targ…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis study tests a new treatment for people with EBV-positive Hodgkin or non-Hodgkin lymphoma that has returned or not gone away. The treatment uses the patient's own T-cells, which are modified with a gene called C7R to help them live longer and better attack cancer cells. The m…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
Supercharged immune cells take on hard-to-treat cancers
Disease control Recruiting nowThis early-phase trial tests a new type of immunotherapy for adults with solid tumors that have a protein called GPC3 on their surface. Researchers take a patient's own T cells, add genes to help them recognize and attack GPC3-positive cancer cells, and also include a safety swit…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New program empowers kids with diabetes to thrive
Disease control Recruiting nowThis study tests a program that helps kids aged 10-13 with type 1 diabetes and their parents find and build on the child's strengths. The goal is to improve blood sugar control, daily diabetes care, and quality of life. The program involves youth, parents, and diabetes care provi…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
Engineered t cells target deadly brain cancers in new trial
Disease control Recruiting nowThis study tests a new treatment for people with brain tumors that have a protein called GD2. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack the tumor. A special gene is added to help these cells survive longer in th…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New pacing technique aims to improve life for heart failure patients
Disease control Recruiting nowThis study tests a newer pacing method (His or left bundle branch pacing) against the standard method (biventricular pacing) in over 2,000 adults with heart failure and a wide QRS or high pacing need. The goal is to see which approach better improves quality of life, reduces hosp…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
Veterans' gulf war illness trial tests growth hormone for belly fat and symptoms
Disease control Recruiting nowThis study tests whether growth hormone replacement therapy is safe and effective for veterans with Gulf War Illness who also have a growth hormone deficiency. About 20 veterans will receive the hormone for 6 months, and researchers will measure changes in belly fat, symptoms, an…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New combo therapy aims to stop mesothelioma return after surgery
Disease control Recruiting nowThis study tests whether a combination of immunotherapy drugs (durvalumab and tremelimumab) alone or with chemotherapy can help people with a type of lung cancer called pleural mesothelioma that can be removed with surgery. The goal is to see if these treatments can keep the canc…
Phase: PHASE1, PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Can a protein infusion cut dangerous fluid buildup in liver disease?
Disease control Recruiting nowThis study tests whether giving a higher dose of albumin (a protein) to people with advanced liver cirrhosis and hard-to-treat fluid buildup (ascites) can reduce the need for frequent fluid drainage procedures. About 100 adults with cirrhosis and refractory ascites will receive e…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Supercharged immune cells take on tough blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with T-cell leukemia or lymphoma that has come back. Doctors take a patient's (or their donor's) immune cells, add a special receptor that helps them recognize and attack cancer cells, and give them back. The goal is to see …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Engineered immune cells take on childhood cancers in first human test
Disease control Recruiting nowThis early-phase trial tests a new treatment called CARE T cells for children whose solid tumors (like liver cancer or Wilms tumor) have returned or not responded to standard care. The treatment involves taking a patient's own immune cells, adding special genes to help them recog…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Supercharged t-cells take on hard-to-treat blood cancers
Disease control Recruiting nowThis study tests a new immune therapy for people with advanced B-cell lymphoma or leukemia that has returned or not responded to standard treatment. Researchers take a patient's own T-cells, add a special receptor (CAR) that targets the CD19 protein on cancer cells, and give them…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Immune cells take aim at myeloma in early trial
Disease control Recruiting nowThis early-phase study tests a new therapy using a patient's own immune cells (T cells) trained to attack proteins found on myeloma cells. It includes adults with active multiple myeloma or high-risk precursor conditions (MGUS or smoldering myeloma). The main goals are to find a …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for kids with rare cancer: simpler drug may work better than standard care
Disease control Recruiting nowThis study tests whether a single chemotherapy drug, cytarabine, works better than the usual two-drug combination (vinblastine/prednisone) for treating Langerhans cell histiocytosis (LCH), a rare cancer that causes tissue damage. About 124 children and young adults up to age 21 w…
Phase: PHASE3 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-stage trial tests a new treatment for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. Doctors take a patient's own immune cells (T cells), modify them in the lab to recognize and attack cancer cells carrying the CD7 prot…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Engineered immune cells take aim at hard-to-treat t-cell cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with T-cell leukemia or lymphoma that has come back. The treatment uses the patient's own immune cells (T cells) that have been modified in a lab to recognize and attack cancer cells carrying a protein called CD7. The goal i…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Groundbreaking fetal surgery aims to save babies with severe abdominal defect
Disease control Recruiting nowThis study tests if a special surgery before birth can safely repair a severe birth defect called complex gastroschisis, where the baby's intestines grow outside the belly. Ten pregnant women will receive a fetoscopic procedure to put the intestines back inside and close the skin…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Engineered immune cells take on sarcoma in new combo trial
Disease control Recruiting nowThis early-stage study is testing whether a new type of immune cell therapy, called HER2-CAR T cells, combined with drugs that boost the immune system (pembrolizumab or nivolumab), is safe for people with advanced sarcoma. About 25 participants will receive chemotherapy before th…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New method could make Half-Matched stem cell transplants safer
Disease control Recruiting nowThis study is for people who need a stem cell transplant but only have a half-matched donor, like a parent or child. The goal is to reduce the risk of graft-versus-host disease (GvHD), where donor cells attack the patient's body. Researchers will use a device to select only the C…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New combo therapy takes on Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis early-stage trial tests a new combination treatment for people with advanced HER2-positive solid tumors (like breast, lung, or stomach cancer). Participants receive an injection of a special virus directly into one tumor to activate the immune system, followed by an infusion…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Supercharged t cells take on deadly brain tumors
Disease control Recruiting nowThis early-phase trial tests a new treatment for adults with a returning type of brain cancer called glioblastoma. The treatment uses the patient's own immune cells (T cells) that are genetically modified in a lab to recognize and attack cancer cells that carry a specific protein…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New stent grafts aim to tame deadly aortic bulges
Disease control Recruiting nowThis study looks at how safe and effective custom-made stents are for treating complex bulges or tears in the main artery (aorta). About 760 people with large or fast-growing aneurysms will receive these special stents. Researchers will track deaths, major complications like hear…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
AI-Powered scope could revolutionize esophageal cancer detection
Diagnosis Recruiting nowThis study tests a mobile, AI-powered microscope that helps doctors spot early signs of esophageal cancer during a routine scope exam. About 200 adults in Brazil and the United States will take part. The goal is to see if the AI tool makes diagnosis more accurate and reduces the …
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated May 26, 2026 08:19 UTC
-
Simple cream may stop painful infections in infant boys
Prevention Recruiting nowThis small study tests whether a steroid cream applied to the penis can prevent repeat urinary tract infections (UTIs) in uncircumcised baby boys under 6 months old who have already had one UTI. Half the babies get the steroid cream, half get a placebo cream, applied twice a week…
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated May 26, 2026 09:03 UTC
-
Can a phone app help hispanic teens beat diabetes risk?
Prevention Recruiting nowThis study is testing a mobile health app to help Hispanic teenagers (ages 12-18) who are overweight improve their diet, physical activity, and sleep. The goal is to see if the app is easy to use and can help prevent type 2 diabetes. Thirty participants will use the app for 30 da…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated May 26, 2026 08:33 UTC
-
Food rx for kids: can a prescription for healthy eating prevent disease?
Prevention Recruiting nowThis study tests if giving parents food prescriptions along with tips on best feeding practices can help prevent chronic diseases like obesity in children. Researchers will work with 375 parents of 4-8 year olds in Texas. The goal is to see if this approach is practical and well-…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated May 22, 2026 14:03 UTC
-
New colon scope tool aims to cut surgery time in half
Symptom relief Recruiting nowThis study tests a new device called Pathfinder that stiffens the scope during colon tumor removal. The goal is to see if it makes the procedure faster and safer than the usual method. About 66 adults with certain colon growths will take part. If it works, patients may have short…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 09:07 UTC
-
Gadget may make colon surgery faster and safer
Symptom relief Recruiting nowThis study compares two ways to remove abnormal growths from the colon: standard endoscopic surgery (ESD) versus using a special traction device that pulls the growth for better access. Researchers want to see if the device makes the procedure faster and reduces complications. Ab…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 09:03 UTC
-
Can a 2-Day therapy boost Veterans' mental health?
Symptom relief Recruiting nowThis study tests two fast-paced versions of cognitive behavioral therapy for veterans with PTSD and anxiety disorders. About 306 veterans will receive either individual therapy over two weeks, group therapy over two days, or usual care. The goal is to see which format better redu…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 09:00 UTC
-
New program aims to boost quality of life for ovarian cancer survivors
Symptom relief Recruiting nowThis study tests a special support program called POSTCARE-O for women with ovarian cancer who have finished their initial treatment. The goal is to see if this program can improve quality of life and reduce depression compared to usual care. The study will involve 120 women and …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 08:58 UTC
-
New knife could make esophageal surgery safer and faster
Symptom relief Recruiting nowThis study tests a new type of knife that uses bipolar radiofrequency energy to remove precancerous growths from the esophagus. About 50 adults will take part to see if the tool works well and is safe. The goal is to make the procedure faster and reduce the risk of injury.
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 08:56 UTC
-
Magic mushroom therapy targets PTSD in veterans
Symptom relief Recruiting nowThis study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can safely reduce PTSD symptoms in US Veterans. Fifteen participants will receive two guided psilocybin sessions. The goal is to see if this approach is safe and helps ease t…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 08:33 UTC
-
New device tested for swallowing surgery
Symptom relief Recruiting nowThis study looks at how safe and effective a special device called Speedboat UltraSlim™ is when used during a surgery called POEM to treat swallowing problems like achalasia. About 40 adults who are already scheduled for this surgery will have their medical records reviewed. The …
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC
-
Could a gentle brain zapping combo calm Alzheimer's agitation?
Symptom relief Recruiting nowThis pilot study tests whether combining two non-invasive brain stimulation methods—iTBS and tDCS—can safely ease neuropsychiatric symptoms like mood swings, apathy, and agitation in people with Alzheimer's disease. Twenty veterans aged 60-85 with mild to moderate Alzheimer's wil…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC
-
Ear zaps may sharpen Veterans' minds after brain injury
Symptom relief Recruiting nowThis study tests a non-invasive device that sends mild electrical pulses to the ear to stimulate the vagus nerve. Researchers want to see if it can improve attention and memory in 30 veterans with traumatic brain injury, depression, or PTSD. Participants will try both the real st…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC
-
Bright light therapy shows promise for brain tumor Survivors' fatigue
Symptom relief Recruiting nowThis study tests whether daily exposure to bright light can help reduce fatigue and improve thinking skills in children and teens who have been treated for a brain tumor. The study involves 40 participants who will use a light box at home for 6 weeks. The goal is to see if this a…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC
-
Bandage-Sized sensor could revolutionize hydrocephalus monitoring
Knowledge-focused Recruiting nowThis study tests a new wireless, bandage-like sensor called FlowSense that measures fluid flow in the brain for people with hydrocephalus. The sensor is placed on the neck to check if a shunt is working without needing X-rays or hospital equipment. Researchers will compare its re…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:10 UTC
-
Scientists hunt for the gene behind rare brain disorder
Knowledge-focused Recruiting nowThis study is trying to find the specific gene that causes Aicardi syndrome, a rare brain disorder. Researchers are collecting blood and skin samples from up to 500 people with the condition and their parents to analyze their DNA. The goal is to identify genetic changes unique to…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:08 UTC
-
Massive study seeks genetic clues for rare eye conditions in kids
Knowledge-focused Recruiting nowThis research study aims to learn more about the physical traits and genetic changes linked to microphthalmia, anophthalmia, and coloboma (MAC) in children. Researchers will collect medical histories, saliva, and blood samples, and perform detailed exams including eye tests and b…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:05 UTC
-
New study aims to close deadly TB gaps in HIV patients
Knowledge-focused Recruiting nowThis study looks for better ways to find and prevent tuberculosis (TB) in people living with HIV, especially children and teens. Researchers will test a new screening method and a support program to help patients complete TB prevention treatment. The goal is to reduce TB deaths, …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:04 UTC
-
500 kids with severe obesity to help unlock genetic secrets
Knowledge-focused Recruiting nowThis study gathers information from 500 children with severe, early-onset obesity to learn which genes may be involved. Researchers will look at genetic test results and track body mass index over time. No treatment or intervention is given—this is purely an observational databas…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:02 UTC
-
Can tackling food insecurity boost child brain development?
Knowledge-focused Recruiting nowThis study aims to help families with food insecurity and mothers with depression. Researchers will provide resources like food, rent help, and mental health support to see if it improves the bond between mother and child. The study includes 2,000 caregivers of young children in …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:01 UTC
-
Scientists probe Brain's social circuits to unlock mood disorder secrets
Knowledge-focused Recruiting nowThis study aims to understand how the brain processes social and emotional information in people with treatment-resistant depression or epilepsy. Researchers will use special electrodes placed inside the brain to record activity while participants perform mood-related tasks. The …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 09:00 UTC
-
Can a simple nutrient help teens with diabetes?
Knowledge-focused Recruiting nowThis study looks at how the amino acid arginine works in the bodies of young people with type 2 diabetes. Researchers will compare 30 teens with diabetes to healthy teens to see if arginine affects insulin release. The goal is to learn more about the disease and test if arginine …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:59 UTC
-
New study aims to diagnose rare diseases in newborns using virtual genetic consultations
Knowledge-focused Recruiting nowThis study offers advanced genetic testing and virtual doctor consultations for seriously ill newborns in Texas hospitals with limited resources, especially near the Texas-Mexico border. Researchers will test a tool called Consultagene to see if it helps doctors diagnose rare gen…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:58 UTC
-
New standard care for fetal bladder blockage under study
Knowledge-focused Recruiting nowThis study aims to see if a standard prenatal care plan helps babies with a blocked bladder (LUTO) survive and have better kidney function. Researchers will track 50 pregnant women and their babies from diagnosis to 24 months after birth. The goal is to improve outcomes by follow…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:58 UTC
-
Study tests if extra drug can reduce anesthesia in kids
Knowledge-focused Recruiting nowThis study looks at how two different doses of a sedative called dexmedetomidine change the amount of anesthesia (sevoflurane) needed to prevent movement during surgery in children aged 1 month to 3 years. About 180 children will take part. The goal is to find the right dose to s…
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
Twin surgery study: does entry technique matter?
Knowledge-focused Recruiting nowThis study compares two ways surgeons enter the uterus during laser surgery for twin-to-twin transfusion syndrome. It aims to see if one method causes less separation of the membranes around the babies. About 216 pregnant women between 16 and 26 weeks will take part. The results …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
Scientists use brain implants and AI to decode mood swings
Knowledge-focused Recruiting nowThis study aims to better understand how brain activity relates to mood in people with depression and epilepsy. Researchers will use precise brain recordings and artificial intelligence to analyze mood changes. The goal is to improve treatments for depression and other mental hea…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:20 UTC
-
Animated video aims to curb antibiotic overuse in UTIs
Knowledge-focused Recruiting nowThis study tests whether a short animated video and a picture guide can help patients give a cleaner urine sample, leading to fewer false-positive results and less unnecessary antibiotic use. About 252 adults in primary care clinics will either watch the video and get the guide o…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC
-
New study aims to unlock mysteries of rare genetic disorder
Knowledge-focused Recruiting nowThis study gathers health information and biological samples from 300 people with TANGO2 deficiency, a rare genetic condition. Researchers will track hospitalizations for metabolic and cardiac crises to understand how the disease progresses. The goal is to create a database and b…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Can genes explain HIE? new study sequences Babies' DNA
Knowledge-focused Recruiting nowThis study offers genome sequencing to 25 newborns diagnosed with HIE (a severe brain condition from lack of oxygen at birth) who are undergoing cooling therapy. Researchers want to find out how often genetic changes cause or contribute to HIE. The goal is to learn which babies m…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Scientists infect volunteers with hookworms to test future vaccine
Knowledge-focused Recruiting nowThis study gives healthy adults different doses of hookworm larvae through the skin to find a safe dose that causes a consistent infection. The goal is to create a reliable model for testing a future hookworm vaccine. About 35 people aged 18 to 45 will take part for 6 months.
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Can a skin test reveal your Toddler's veggie intake?
Knowledge-focused Recruiting nowThis study looks at healthy infants and toddlers to see how the fruits and vegetables they eat affect their skin and eyesight. Researchers will measure carotenoid levels in the skin and blood, and test vision over 6 visits from 4 to 24 months old. No treatment is given—only obser…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC